News
Saturday was the day to enjoy and experiment in the Hospitalet science park
This year within the framework of the Hospitalet Spring Festival, we enjoyed again in the Science Park.
We launch VacunAcció: a project to immunize against fake news
IDIBELL and the Virolai school, together in a new educational initiative of the Escolab program of the Barcelona City Council
IDIBELL and Bellvitge Hospital lead a study on the effectiveness of icatibant against COVID-19
Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital had launched a clinical study, along with the pharmaceutical company Takeda, to evaluate the efficacy and safety of Icatibant as a treatment against COVID-19.
Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae
The work of the Epidemiology of Bacterial Infections research group of IDIBELL and HUB indicates that the bacteria could achieve the resistance through the acquisition of mobile DNA fragments.
IDIBELL celebrates the Kickoff Meeting on Health Research Projects awarded by ISCIII
Last Tuesday, April 20th, within the Areté Training Program, the IDIBELL AES-2020 Kick Off Meeting was held, aimed at all researchers who have obtained a health research project within the “2020 AES Call” funded by the ISCIII.
Created the largest public database of genetic variants that regulate the expression of genes in the colon to date
The study has also permitted identify genetic variants that modify the expression of genes in the colon and that are associated with diseases such as colorectal cancer, but also with other organs such as the brain, showing the relationship between the intestine and the brain.
Voice analysis with artificial intelligence models may allow early detection of bulbar involvement in ALS
An investigation by the International Center for Numerical Methods in Engineering (CIMNE) and the University of Lleida (UdL), in which IDIBELL and the Hospital de Bellvitge has participated, has developed automated voice markers to identify early affectations of the disease.